For the first time, mass testing of Ebola medicines

Doctors Without Borders (MSF) will clinically test two antiviral drugs and blood transfusions on hundreds of Ebola patients in Guinea and Liberia in December.

According to CNN, these are unprecedented clinical trials because these methods have not undergone long-term clinical trials in animals and healthy people before being used for patients.

According to Dr. Annick Antierans of MSF, this international cooperation effort represents the hope of finding a true cure for the disease that has so far killed 50-80% of infected people.

Clinical trials of the three treatments will be led by three research teams, focusing on finding effective ways to fight Ebola. Unlike normal patients are divided into two groups using drugs and not using drugs to get comparison results, in this test all patients were given medicine. After that, scientists will monitor the rate of people who get better after 14 days of improvement compared to when not treated with drugs or not.

Clinical trials are expected to help speed up the search for an official Ebola remedy, reducing the mortality rate of deadly plague.(Photo: Reuters)

The first clinical trial was performed with Brincidofovir at a medical center in the capital Monrovia (Liberia). Brincidofovir was previously used for Thomas Eric Duncan, the first Ebola patient in the United States. However, this person died at Texas Health Presbyterian Hospital after a month of treatment. The cinematographer is free of NBC Ashoka Mukpo, the virus infected in Liberia is also treated with this drug during his stay in Nebraska hospital. He recovered and was discharged in October.

The second drug in clinical trials is Favipiravir . The drug is used on patients in Gueckedou town, southern Guinea. Previously, nurse Teresa Romero Ramas, the first Ebola-infected patient outside of Africa, was treated with Favipiravir and recovered. She officially discharged from the hospital in early November this year.

Blood transfusion therapy is the third method in a clinical trial next month, arranged in the capital of Guinea's Conakry. Blood transfusion from Ebola patients escapes death for infected people - although no studies have proven - a promising method recommended by WHO. According to experts, in the serum of people infected with Ebola has recovered from the antibodies that have the ability to resist this deadly virus.

Among Ebola patients treated with blood transfusions are American doctor Kent Brantly, relief worker Rick Sacra and Vietnamese-American nurse Nina Pham. All three patients recovered well.

Publication of clinical trials was launched on November 13 in the context of the worldwide number of Ebola deaths that have surpassed the 5,000 mark.